ICON PLC (NASDAQ: ICLR) is a global contract research organization (CRO) providing outsourced clinical trial and data services to pharmaceutical and biotech companies. With operations in over 40 countries, it supports drug development from early-phase research to post-market surveillance. It offers investors stable, margin-rich exposure to healthcare R&D spending.
Nieuwste artikelen over aandelen